To restore and clarify the intent of the Federal interest rate exportation parity for State-chartered banks by allowing States to opt out of preemption only with respect to loans made by their own chartered institutions, and for other purposes.

HR7866, titled "To restore and clarify the intent of the Federal interest rate exportation parity for State-chartered banks by allowing States to opt out of preemption only with respect to loans made by their own chartered institutions, and for other purposes," was introduced in the House on 2026-03-09 and referred to the House Committee on Financial Services. The bill is in its early stages, with only two actions recorded since its introduction. This bill does not involve direct funding or appropriations. Instead, it proposes a regulatory change that would allow states to opt out of federal interest rate preemption for loans made by their own state-chartered institutions. This mechanism would shift regulatory power from the federal level to individual states, potentially creating a patchwork of interest rate regulations. The primary impact is regulatory relief for state-chartered banks and regional lenders, as they would no longer be at a competitive disadvantage against larger national banks that currently benefit from federal preemption. Structural winners under this proposed legislation would be smaller, state-chartered banks and regional lenders, as they would gain competitive parity in interest rate setting. Structural losers would be large national banks such as JPMorgan Chase & Co. ($JPM), Bank of America Corporation ($BAC), Wells Fargo & Company ($WFC), Citigroup Inc. ($C), and U.S. Bancorp ($USB), as they would face increased regulatory complexity and compliance costs due to varying state regulations. Regional banks like The PNC Financial Services Group, Inc. ($PNC), KeyCorp ($KEY), Fifth Third Bancorp ($FITB), and Citizens Financial Group, Inc. ($CFG) could also experience increased operational burdens if they operate across many states that opt out, though they may also benefit from a more level playing field against the largest national banks. Looking at recent market data, major national banks like JPMorgan Chase & Co. ($JPM) are currently trading at $295.45, up 4.12% over 7 days and 0.65% over 30 days. Bank of America Corporation ($BAC) is at $50.06, up 5.99% over 7 days and 0.5% over 30 days. Wells Fargo & Company ($WFC) is at $81.85, up 6.58% over 7 days but down 0.32% over 30 days. Citigroup Inc. ($C) is at $117.36, up 9.41% over 7 days and 7.72% over 30 days. U.S. Bancorp ($USB) is at $53.44, up 5.03% over 7 days but down 0.87% over 30 days. These large banks have shown recent positive 7-day performance, but their 30-day performance is mixed, with some showing slight declines. The bill's potential impact on these stocks is not yet reflected in these short-term trends, given its early legislative stage. As the bill is currently referred to committee, significant legislative steps remain. It must pass through committee, be voted on by the House, potentially pass the Senate, and then be signed by the President to become law. The sponsorship by Rep. Davidson, Warren [R-OH-8] with one cosponsor indicates a relatively early stage of legislative momentum.